HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-12-22FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for EMTRIVA (emtricitabine) from Gilead Sciences.
-
FDA approval · 2006-12-22FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
The FDA approved a supplemental application for VIRACEPT (nelfinavir) from Agouron. This action approves an additional aspect of the drug's …
-
FDA approval · 2006-12-21FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Kaletra (lopinavir/ritonavir) submitted by AbbVie. The approval relates to its use for HIV infec…
-
FDA approval · 2006-12-21FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2006-11-29Clinical Trial Update: Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection [NA]
A clinical trial evaluated CD4-guided treatment interruption versus continuous antiretroviral therapy for HIV infection, and the study statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-11-20FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
FDA approval · 2006-11-15FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (zidovudine) filed by ViiV Healthcare Company.
-
FDA approval · 2006-11-15FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) from ViiV Healthcare Company.
-
FDA approval · 2006-11-15FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS research · 2006-10-27Clinical Trial Update: SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients [Phase 2]
Phase 2 clinical trial SP01A of an oral entry inhibitor in treatment-experienced HIV patients. The current status is UNKNOWN.
-
FDA approval · 2006-10-25FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
-
FDA label_change · 2006-10-25FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for COMBIVIR (lamivudine and zidovudine) from ViiV Healthcare Company.
-
FDA approval · 2006-10-25FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. This action confirms regulatory approv…
-
CLINICAL_TRIALS trial_result · 2006-10-24Clinical Trial Update: Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy [NA]
A completed clinical trial comparing reduced-dose stavudine versus switching to tenofovir in HIV-infected patients on antiretroviral therapy…
-
CLINICAL_TRIALS trial_result · 2006-10-20Clinical Trial Update: MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, Tanzania [Phase 3]
Phase 3 MEMA Kwa Vijana trial in Mwanza, Tanzania evaluated an adolescent sexual and reproductive health intervention; the trial status is c…
-
FDA approval · 2006-10-16FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2006-10-16Clinical Trial Update: A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity [Phase 2]
A Phase 2 study evaluating CJC-1295 in HIV-infected individuals with visceral obesity has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-10-11Clinical Trial Update: Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz. [Phase 4]
Phase 4 HIV trial evaluating immune reconstitution in treatment-naive patients with CD4 counts <100 cells/mL treated with lopinavir or efavi…
-
CLINICAL_TRIALS trial_result · 2006-10-04Clinical Trial Update: The Role of Naive T-Cells in HIV Pathogenesis
This clinical trial update investigates how naive T-cells may influence HIV pathogenesis. It is sponsored by Bayside Health, but the current…
-
CLINICAL_TRIALS trial_result · 2006-10-02Clinical Trial Update: A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects [Phase 2]
A Phase 2 trial comparing a lopinavir/ritonavir-based therapy with an efavirenz-based standard of care in treatment-naive HIV-infected adult…
-
CLINICAL_TRIALS research · 2006-09-22Clinical Trial Update: Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA [NA]
This document is a clinical trial update evaluating the outcomes of Minority AIDS Initiative programs in the New York EMA, sponsored by The …
-
CLINICAL_TRIALS research · 2006-09-21Clinical Trial Update: Effect Study of a Theory-Based Internet Intervention on Safe-Sex Practices [NA]
A theory-based internet intervention aimed at improving safe-sex practices to reduce HIV infection risk was terminated.
-
CLINICAL_TRIALS research · 2006-09-20Clinical Trial Update: High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease [NA]
An update on a clinical trial evaluating a high-dose ritonavir-boosted lopinavir liquid formulation as salvage therapy for protease inhibito…
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection [Phase 2, Phase 3]
This clinical trial update describes a multicenter Phase 2/3 study comparing three therapeutic strategies in patients with acute primary HIV…
-
CLINICAL_TRIALS trial_result · 2006-08-23Clinical Trial Update: NOW Thai HAART Study
Clinical Trial Update for NOW Thai HAART Study sponsored by the Department of Medical Services, Ministry of Public Health of Thailand. The t…